MedPath
NMPA Approval

Ozagrel Sodium for Injection

国药准字H20163135

March 12, 2021

Drug Information

注射用奥扎格雷钠

注射剂

80mg

化学药品

March 12, 2021

Company Information

Applicant Company

Manufacturing Company

海南省定安塔岭工业区塔中路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用奥扎格雷钠 - NMPA 批准文号 | MedPath